145 related articles for article (PubMed ID: 30569145)
1. Identification of differentially expressed genes in MG63 osteosarcoma cells with drug‑resistance by microarray analysis.
Chen R; Huang LH; Gao YY; Yang JZ; Wang Y
Mol Med Rep; 2019 Mar; 19(3):1571-1580. PubMed ID: 30569145
[TBL] [Abstract][Full Text] [Related]
2. Characterization of multidrug‑resistant osteosarcoma sublines and the molecular mechanisms of resistance.
Yang JZ; Ma SR; Rong XL; Zhu MJ; Ji QY; Meng LJ; Gao YY; Yang YD; Wang Y
Mol Med Rep; 2016 Oct; 14(4):3269-76. PubMed ID: 27498972
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysis.
Zhu KP; Zhang CL; Shen GQ; Zhu ZS
Int J Clin Exp Pathol; 2015; 8(8):8754-73. PubMed ID: 26464619
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of LIMK1 promotes migration ability of multidrug-resistant osteosarcoma cells.
Zhang H; Wang Y; Xing F; Wang J; Wang Y; Wang H; Yang Y; Gao Z
Oncol Res; 2011; 19(10-11):501-9. PubMed ID: 22715593
[TBL] [Abstract][Full Text] [Related]
5. [Sensitivity of doxorubicin-resistant osteosarcoma cells to doxorubicin regulated by long non-coding RNA NR_036444].
Zhu KP; Zhang CL
Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):250-255. PubMed ID: 28550663
[No Abstract] [Full Text] [Related]
6. Transfer of exosomal microRNAs confers doxorubicin resistance in osteosarcoma cells.
Cai T; Zhang C; Zhan T
Mol Med Rep; 2023 Apr; 27(4):. PubMed ID: 36866739
[TBL] [Abstract][Full Text] [Related]
7. Stathmin is key in reversion of doxorubicin resistance by arsenic trioxide in osteosarcoma cells.
Feng T; Qiao G; Feng L; Qi W; Huang Y; Yao Y; Shen Z
Mol Med Rep; 2014 Dec; 10(6):2985-92. PubMed ID: 25310700
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells.
Pan W; Wang H; Jianwei R; Ye Z
Cell Physiol Biochem; 2014; 33(2):402-12. PubMed ID: 24556602
[TBL] [Abstract][Full Text] [Related]
9. [Establishment of a cisplatin-multidrug resistance cell line of human osteosarcoma].
Zhang WT; Tu CQ; Liu Y; Li SF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):262-5. PubMed ID: 16608090
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA‑22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma.
Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Sun L; Sun C; Feng W; Guo SB
Mol Med Rep; 2020 Nov; 22(5):3911-3921. PubMed ID: 33000186
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Stim1 expression is associated with acquired chemo-resistance of cisplatin in osteosarcoma cells.
Sun X; Wei Q; Cheng J; Bian Y; Tian C; Hu Y; Li H
Hum Cell; 2017 Jul; 30(3):216-225. PubMed ID: 28326487
[TBL] [Abstract][Full Text] [Related]
12. Targeting DNA-PKcs increased anticancer drug sensitivity by suppressing DNA damage repair in osteosarcoma cell line MG63.
Li X; Tian J; Bo Q; Li K; Wang H; Liu T; Li J
Tumour Biol; 2015 Dec; 36(12):9365-72. PubMed ID: 26108997
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA LARP4 correlates with decreased Enneking stage, better histological response, and prolonged survival profiles, and it elevates chemosensitivity to cisplatin and doxorubicin via sponging microRNA-424 in osteosarcoma.
Hu Y; Gu J; Shen H; Shao T; Li S; Wang W; Yu Z
J Clin Lab Anal; 2020 Feb; 34(2):e23045. PubMed ID: 31642110
[TBL] [Abstract][Full Text] [Related]
14. The overexpression of MRP4 is related to multidrug resistance in osteosarcoma cells.
He Z; Hu B; Tang L; Zheng S; Sun Y; Sheng Z; Yao Y; Lin F
J Cancer Res Ther; 2015; 11(1):18-23. PubMed ID: 25879330
[TBL] [Abstract][Full Text] [Related]
15. Differentially expressed genes in multidrug resistant variants of U-2 OS human osteosarcoma cells.
Chano T; Mori K; Scotlandi K; Benini S; Lapucci C; Manara MC; Serra M; Picci P; Okabe H; Baldini N
Oncol Rep; 2004 Jun; 11(6):1257-63. PubMed ID: 15138564
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine kinase 1 contributes to doxorubicin resistance and glycolysis in osteosarcoma.
Ren X; Su C
Mol Med Rep; 2020 Sep; 22(3):2183-2190. PubMed ID: 32705189
[TBL] [Abstract][Full Text] [Related]
17. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K
Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705
[TBL] [Abstract][Full Text] [Related]
18. Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance.
Wang DY; Wu YN; Huang JQ; Wang W; Xu M; Jia JP; Han G; Mao BB; Bi WZ
Chin J Cancer; 2016 May; 35():47. PubMed ID: 27206784
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of MSH6 gene silencing in combination with cisplatin on cell proliferation of human osteosarcoma cell line MG63.
Liu HC; Zeng J; Zhang B; Liu XQ; Dai M
J Cell Physiol; 2019 Jun; 234(6):9358-9369. PubMed ID: 30456894
[TBL] [Abstract][Full Text] [Related]
20. Polydatin enhances the chemosensitivity of osteosarcoma cells to paclitaxel.
Zhao W; Chen Z; Guan M
J Cell Biochem; 2019 Oct; 120(10):17481-17490. PubMed ID: 31106479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
